Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Green, B. J.
Right arrow Articles by Hart, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Green, B. J.
Right arrow Articles by Hart, D. N.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol 10, 891-899, Copyright © 1998 by Oxford University Press


ARTICLES

The CMRF-35 mAb recognizes a second leukocyte membrane molecule with a domain similar to the poly Ig receptor

BJ Green, GJ Clark and DN Hart
Haematology/Immunology/Transfusion Medicine Research Group, Christchurch School of Medicine, New Zealand.

The CMRF-35 mAb recognizes an antigen found on most leukocytes including monocytes, neutrophils, macrophages, dendritic cells, and subpopulations of lymphocytes and bone marrow cells. A cDNA expressing the CMRF-35 epitope was isolated by expression cloning and this predicts for a type I cell surface glycoprotein belonging to the Ig superfamily. Here we demonstrate that the CMRF-35 mAb recognizes an epitope more widely distributed on hemopoietic cells and cell lines than suggested by expression analysis of the CMRF-35 mRNA. Furthermore, we have isolated a novel cDNA (CMRF-35-H9) that encodes a protein product also recognized by the CMRF-35 mAb. This cDNA product is a type I cell surface glycoprotein with a single Ig V-like domain. Although the sequences of the extracellular V-like domains of the two molecules are very similar, there is little similarity between the remainder of their sequences. The two transcripts are expressed independently of each other, and their presence accounts for the discrepancy between CMRF-35 mAb binding and mRNA analysis. The cytoplasmic tail of CMRF-35- H9 contains motifs similar to the inhibitory motifs found in some leukocyte surface receptors. Their expression in hemopoietic cells suggests that these two molecules may play distinct but related roles in the regulation of leukocyte function.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BloodHome page
X. Ju, M. Zenke, D. N. J. Hart, and G. J. Clark
CD300a/c regulate type I interferon and TNF-{alpha} secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands
Blood, August 15, 2008; 112(4): 1184 - 1194.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Yamanishi, J. Kitaura, K. Izawa, T. Matsuoka, T. Oki, Y. Lu, F. Shibata, S. Yamazaki, H. Kumagai, H. Nakajima, et al.
Analysis of mouse LMIR5/CLM-7 as an activating receptor: differential regulation of LMIR5/CLM-7 in mouse versus human cells
Blood, January 15, 2008; 111(2): 688 - 698.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
G. J. Clark, M. Rao, X. Ju, and D. N. J. Hart
Novel human CD4+ T lymphocyte subpopulations defined by CD300a/c molecule expression
J. Leukoc. Biol., November 1, 2007; 82(5): 1126 - 1135.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Izawa, J. Kitaura, Y. Yamanishi, T. Matsuoka, T. Oki, F. Shibata, H. Kumagai, H. Nakajima, M. Maeda-Yamamoto, J. P. Hauchins, et al.
Functional Analysis of Activating Receptor LMIR4 as a Counterpart of Inhibitory Receptor LMIR3
J. Biol. Chem., June 22, 2007; 282(25): 17997 - 18008.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Alvarez-Errico, J. Sayos, and M. Lopez-Botet
The IREM-1 (CD300f) Inhibitory Receptor Associates with the p85{alpha} Subunit of Phosphoinositide 3-Kinase
J. Immunol., January 15, 2007; 178(2): 808 - 816.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Fujimoto, H. Takatsu, and H. Ohno
CMRF-35-like molecule-5 constitutes novel paired receptors, with CMRF-35-like molecule-1, to transduce activation signal upon association with FcR{gamma}
Int. Immunol., October 1, 2006; 18(10): 1499 - 1508.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Martinez-Barriocanal and J. Sayos
Molecular and Functional Characterization of CD300b, a New Activating Immunoglobulin Receptor Able to Transduce Signals through Two Different Pathways.
J. Immunol., September 1, 2006; 177(5): 2819 - 2830.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
E. Umemoto, T. Tanaka, H. Kanda, S. Jin, K. Tohya, K. Otani, T. Matsutani, M. Matsumoto, Y. Ebisuno, M. H. Jang, et al.
Nepmucin, a novel HEV sialomucin, mediates L-selectin-dependent lymphocyte rolling and promotes lymphocyte adhesion under flow
J. Exp. Med., June 12, 2006; 203(6): 1603 - 1614.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Zhao, S. Maruo, A. Cooper, M. R. Chase, E. Johannsen, E. Kieff, and E. Cahir-McFarland
RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines
PNAS, February 7, 2006; 103(6): 1900 - 1905.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Aguilar, D. Alvarez-Errico, A. C. Garcia-Montero, A. Orfao, J. Sayos, and M. Lopez-Botet
Molecular Characterization of a Novel Immune Receptor Restricted to the Monocytic Lineage
J. Immunol., December 1, 2004; 173(11): 6703 - 6711.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D.-H. Chung, M. B. Humphrey, M. C. Nakamura, D. G. Ginzinger, W. E. Seaman, and M. R. Daws
CMRF-35-Like Molecule-1, a Novel Mouse Myeloid Receptor, Can Inhibit Osteoclast Formation
J. Immunol., December 15, 2003; 171(12): 6541 - 6548.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
K. Yotsumoto, Y. Okoshi, K. Shibuya, S. Yamazaki, S. Tahara-Hanaoka, S.-i. Honda, M. Osawa, A. Kuroiwa, Y. Matsuda, D. G. Tenen, et al.
Paired Activating and Inhibitory Immunoglobulin-like Receptors, MAIR-I and MAIR-II, Regulate Mast Cell and Macrophage Activation
J. Exp. Med., July 21, 2003; 198(2): 223 - 233.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. Mason, P. Andre, A. Bensussan, C. Buckley, C. Civin, E. Clark, M. de Haas, S. Goyert, M. Hadam, D. Hart, et al.
CD antigens 2002
Blood, May 15, 2002; 99(10): 3877 - 3880.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. Mason, P. Andre, A. Bensussan, C. Buckley, C. Civin, E. Clark, M. de Haas, S. Goyert, M. Hadam, D. Hart, et al.
CD antigens 2001
J. Leukoc. Biol., November 1, 2001; 70(5): 685 - 690.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. A. Hawke, J. A. Yoder, R. N. Haire, M. G. Mueller, R. T. Litman, A. L. Miracle, T. Stuge, L. Shen, N. Miller, and G. W. Litman
Extraordinary variation in a diversified family of immune-type receptor genes
PNAS, October 31, 2001; (2001) 231418598.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Fournier, L. Chalus, I. Durand, E. Garcia, J.-J. Pin, T. Churakova, S. Patel, C. Zlot, D. Gorman, S. Zurawski, et al.
FDF03, a Novel Inhibitory Receptor of the Immunoglobulin Superfamily, Is Expressed by Human Dendritic and Myeloid Cells
J. Immunol., August 1, 2000; 165(3): 1197 - 1209.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. A. Hawke, J. A. Yoder, R. N. Haire, M. G. Mueller, R. T. Litman, A. L. Miracle, T. Stuge, L. Shen, N. Miller, and G. W. Litman
Extraordinary variation in a diversified family of immune-type receptor genes
PNAS, November 20, 2001; 98(24): 13832 - 13837.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.